An alert on GeneDx Holdings Corp WGS.O exiting its reproductive and somatic tumor testing businesses has been withdrawn as the news is dated.
The company had announced the news in statements in 2022 and 2023.
STORY_NUMBER: nFWN3W90DM
STORY_DATE: 28/10/2025
STORY_TIME: 10:59:03 AM GMT
((Bangalore.newsroom@thomsonreuters.com))